Kamil P. Grela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kamil P. Grela has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bożena Karolewicz
Department of Drug Form Technology, Wroclaw Medical University, Borowska 211 A, 50-556 Wroclaw, Poland
2 shared publications - Anna Kusakiewicz-Dawid
Faculty of Chemistry, University of Opole, 45-052 Opole, Poland
1 shared publication - Anna Szewczyk
Department of Molecular and Cellular Biology, Wroclaw Medical University, 50-556 Wroclaw, Poland
1 shared publication - Anna Szyjka
Department of Basic Medical Science, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland
1 shared publication D. M. Marciniak
Wroclaw Med Univ, Fac Pharm, Dept Drugs Form Technol, Borowska 211A, PL-50556 Wroclaw, Poland
1 shared publication- Dominik Marciniak
Department and Division of Pharmaceutical Technology, Faculty of Pharmacy, Wrocław Medical University, 50-556 Wrocław, Poland
1 shared publication
Latest Publications
- Open Access
Poloxamer 407-Based Thermosensitive Emulgel as a Novel Formulation Providing a Controlled Release of Oil-Soluble Pharmaceuticals—Ibuprofen Case Study
This article covers the design and evaluation of a novel drug vehicle: a thermosensitive, injectable, high-oil-content (50% w/w) emulgel providing a controlled release of lipophilic pharmaceuticals. Different vegetable (castor, canola, olive, peanut, grapeseed, linseed), mineral (paraffin) and semisynthetic (isopropyl myristate, oleic acid) oils were screened for ibuprofen (IBU) solubility and for their capacity for high-shear emulsification in a 17% (w/w) aqueous solution of poloxamer 407. Chosen emulgels were subject to a rheological evaluation, a syringeability test (TA.XT texture analyser; 2 mL syringe; 18 G, 20 G and 22 G needles) and a drug release study (48 h; cellulose membrane; 0.05 mol/L phosphate buffer at pH 7.4). Castor oil turned out to be an optimal component for IBU incorporation. Blank and drug-loaded castor oil emulgels were susceptible to administration via a syringe and needle, with the absolute injection force not exceeding 3 kg (29.4 N). The drug release test revealed dose-dependent, quasi-linear kinetics, with up to 44 h of controlled, steady, linear release. The results indicate the significant potential of high-oil-content, oil-in-water thermosensitive emulgel formulations as vehicles for the controlled release of lipophilic APIs.
Open AccessPoloxamer 407-Based Thermosensitive Emulgel as a Novel Formulation Providing a Controlled Release of Oil-Soluble Pharmaceuticals—Ibuprofen Case Study
This article covers the design and evaluation of a novel drug vehicle: a thermosensitive, injectable, high-oil-content (50% w/w) emulgel providing a controlled release of lipophilic pharmaceuticals. Different vegetable (castor, canola, olive, peanut, grapeseed, linseed), mineral (paraffin) and semisynthetic (isopropyl myristate, oleic acid) oils were screened for ibuprofen (IBU) solubility and for their capacity for high-shear emulsification in a 17% (w/w) aqueous solution of poloxamer 407. Chosen emulgels were subject to a rheological evaluation, a syringeability test (TA.XT texture analyser; 2 mL syringe; 18 G, 20 G and 22 G needles) and a drug release study (48 h; cellulose membrane; 0.05 mol/L phosphate buffer at pH 7.4). Castor oil turned out to be an optimal component for IBU incorporation. Blank and drug-loaded castor oil emulgels were susceptible to administration via a syringe and needle, with the absolute injection force not exceeding 3 kg (29.4 N). The drug release test revealed dose-dependent, quasi-linear kinetics, with up to 44 h of controlled, steady, linear release. The results indicate the significant potential of high-oil-content, oil-in-water thermosensitive emulgel formulations as vehicles for the controlled release of lipophilic APIs.
- Open Access
The Impact of Extracellular Ca2+ and Nanosecond Electric Pulses on Sensitive and Drug-Resistant Human Breast and Colon Cancer Cells
(1) Background: Calcium electroporation (CaEP) is based on the application of electrical pulses to permeabilize cells (electroporation) and allow cytotoxic doses of calcium to enter the cell. (2) Methods: In this work, we have used doxorubicin-resistant (DX) and non-resistant models of human breast cancer (MCF-7/DX, MCF-7/WT) and colon cancer cells (LoVo, LoVo/DX), and investigated the susceptibility of the cells to extracellular Ca2+ and electric fields in the 20 ns–900 ns pulse duration range. (3) Results: We have observed that colon cancer cells were less susceptible to PEF than breast cancer cells. An extracellular Ca2+ (2 mM) with PEF was more disruptive for DX-resistant cells. The expression of glycoprotein P (MDR1, P-gp) as a drug resistance marker was detected by the immunofluorescent (CLSM) method and rhodamine-123 efflux as an MDR1 activity. MDR1 expression was not significantly modified by nanosecond electroporation in multidrug-resistant cells, but a combination with calcium ions significantly inhibited MDR1 activity and cell viability. (4) Conclusions: We believe that PEF with calcium ions can reduce drug resistance by inhibiting drug efflux activity. This phenomenon of MDR mechanism disruption seems promising in anticancer protocols.
Open AccessThe Impact of Extracellular Ca2+ and Nanosecond Electric Pulses on Sensitive and Drug-Resistant Human Breast and Colon Cancer Cells
(1) Background: Calcium electroporation (CaEP) is based on the application of electrical pulses to permeabilize cells (electroporation) and allow cytotoxic doses of calcium to enter the cell. (2) Methods: In this work, we have used doxorubicin-resistant (DX) and non-resistant models of human breast cancer (MCF-7/DX, MCF-7/WT) and colon cancer cells (LoVo, LoVo/DX), and investigated the susceptibility of the cells to extracellular Ca2+ and electric fields in the 20 ns–900 ns pulse duration range. (3) Results: We have observed that colon cancer cells were less susceptible to PEF than breast cancer cells. An extracellular Ca2+ (2 mM) with PEF was more disruptive for DX-resistant cells. The expression of glycoprotein P (MDR1, P-gp) as a drug resistance marker was detected by the immunofluorescent (CLSM) method and rhodamine-123 efflux as an MDR1 activity. MDR1 expression was not significantly modified by nanosecond electroporation in multidrug-resistant cells, but a combination with calcium ions significantly inhibited MDR1 activity and cell viability. (4) Conclusions: We believe that PEF with calcium ions can reduce drug resistance by inhibiting drug efflux activity. This phenomenon of MDR mechanism disruption seems promising in anticancer protocols.
- Open Access
- 14 June 2021
- Published by Polish Pharmaceutical Society in Farmacja Polska
- Vol. 77 (5) , 329-336
Role of diet and nutrition treatment methods in reducing the ailment of the irritable bowel syndrome
- 14 June 2021
- Published by Polish Pharmaceutical Society in Farmacja Polska
- Vol. 77 (5) , 329-336
Open AccessRole of diet and nutrition treatment methods in reducing the ailment of the irritable bowel syndrome
- 1 June 2019
- Vol. 74 (6) , 334-339
Natural gums as viscosity-enhancers in Pluronic® F-127 thermogelling solutions
Pluronic (R) F-127 (poloxamer 407) is a versatile pharmaceutical excipient, offering many opportunities for designing novel therapeutic systems. One of its applications is the formation of a thermosensitive solution as a base for concentrated suspensions or emulsions. When such uses are considered, the need for viscosity enhancement emerges, especially when a long-term stability of dispersion is expected. This study covers the evaluation of chosen natural gums (Acacia, Xanthan Gum, Tragacanth and Guar Gum) as viscosity and gelation enhancers for thermosensitive Pluronic F-127 solution. The major poloxamer concentration was 17 % (w/w), and the gum additions were in the range of 0.125 - 0.5 %. Solutions were evaluated by rotational rheometry at fixed temperatures (20, 25 and 37 degrees C), as well as with continuous temperature increase and decrease. These studies were also supplied by visual inspection during the Tube Inversion Method experiments. Xanthan Gum turned out to be the most effective viscosity enhancer, giving transparent and stable formulations, while Tragacanth gave lesser viscosity enhancement and left the formulations slightly turbid. Acacia significantly inhibited the gelation, and Guar Gum revealed a major incompatibility (precipitation) with poloxamer. Irreversible gelation was not observed in any case.
- 1 June 2019
- Vol. 74 (6) , 334-339
Natural gums as viscosity-enhancers in Pluronic® F-127 thermogelling solutions
Pluronic (R) F-127 (poloxamer 407) is a versatile pharmaceutical excipient, offering many opportunities for designing novel therapeutic systems. One of its applications is the formation of a thermosensitive solution as a base for concentrated suspensions or emulsions. When such uses are considered, the need for viscosity enhancement emerges, especially when a long-term stability of dispersion is expected. This study covers the evaluation of chosen natural gums (Acacia, Xanthan Gum, Tragacanth and Guar Gum) as viscosity and gelation enhancers for thermosensitive Pluronic F-127 solution. The major poloxamer concentration was 17 % (w/w), and the gum additions were in the range of 0.125 - 0.5 %. Solutions were evaluated by rotational rheometry at fixed temperatures (20, 25 and 37 degrees C), as well as with continuous temperature increase and decrease. These studies were also supplied by visual inspection during the Tube Inversion Method experiments. Xanthan Gum turned out to be the most effective viscosity enhancer, giving transparent and stable formulations, while Tragacanth gave lesser viscosity enhancement and left the formulations slightly turbid. Acacia significantly inhibited the gelation, and Guar Gum revealed a major incompatibility (precipitation) with poloxamer. Irreversible gelation was not observed in any case.